Amedeo Smart

Free Medical Literature Service


 

Amedeo

Bladder Cancer

  Free Subscription

Articles published in
Int J Cancer
    March 2021
  1. TREVISANI F, Di Marco F, Raggi D, Bettiga A, et al
    Renal function outcomes in patients with muscle-invasive bladder cancer treated with neoadjuvant pembrolizumab and radical cystectomy in the pure-01 study.
    Int J Cancer. 2021 Mar 15. doi: 10.1002/ijc.33554.
    >> Share

    February 2021
  2. VAN DOEVEREN T, Nakauma-Gonzalez JA, Mason AS, van Leenders GJLH, et al
    The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder.
    Int J Cancer. 2021;148:981-987.
    >> Share

    January 2021
  3. KOUTROS S, Decker KL, Baris D, Pardo LA, et al
    Bladder Cancer Risk Associated with Family History of Cancer.
    Int J Cancer. 2021 Jan 27. doi: 10.1002/ijc.33486.
    >> Share

    October 2020
  4. OZGUN G, Senturk S, Erkek-Ozhan S
    Retinoic acid signaling and bladder cancer: Epigenetic deregulation, therapy and beyond.
    Int J Cancer. 2020 Oct 31. doi: 10.1002/ijc.33374.
    >> Share

  5. WIECZOREK E, Garstka MA
    Recurrent Bladder Cancer in Aging Societies: Importance of Major Histocompatibility Complex Class I Antigen Presentation.
    Int J Cancer. 2020 Oct 26. doi: 10.1002/ijc.33359.
    >> Share

    July 2020
  6. ZHOU Q, Zhang H, Wang Z, Zeng H, et al
    Poor clinical outcomes and immunoevasive contexture in interleukin-9 abundant muscle-invasive bladder cancer.
    Int J Cancer. 2020 Jul 31. doi: 10.1002/ijc.33237.
    >> Share

    June 2020
  7. DIANATINASAB M, Wesselius A, Salehi-Abargouei A, Yu EYW, et al
    Adherence to a Western dietary pattern and risk of bladder cancer: a pooled analysis of 13 Cohort Studies of the Bladder Cancer Epidemiology and Nutritional Determinants (BLEND) International Study.
    Int J Cancer. 2020 Jun 24. doi: 10.1002/ijc.33173.
    >> Share

  8. XU T, Li HT, Wei J, Li M, et al
    Epigenetic plasticity potentiates a rapid cyclical shift to and from an aggressive cancer phenotype.
    Int J Cancer. 2020;146:3065-3076.
    >> Share

    May 2020
  9. LI Y, Hendryx MS, Xun P, He K, et al
    Physical activity and risk of bladder cancer among postmenopausal women.
    Int J Cancer. 2020 May 10. doi: 10.1002/ijc.33042.
    >> Share

  10. SJODAHL G, Eriksson P, Patschan O, Marzouka NA, et al
    Molecular changes during progression from nonmuscle invasive to advanced urothelial carcinoma.
    Int J Cancer. 2020;146:2636-2647.
    >> Share

    April 2020
  11. HIEN TT, Ambite I, Butler D, Wan MLY, et al
    Bladder cancer therapy without toxicity - A dose-escalation study of alpha1-oleate.
    Int J Cancer. 2020 Apr 22. doi: 10.1002/ijc.33019.
    >> Share

  12. JOCHEMS SHJ, Reulen RC, van Osch FHM, Witlox WJA, et al
    Fruit consumption and the risk of bladder cancer: a pooled analysis by the BLadder cancer Epidemiology and Nutritional Determinants study.
    Int J Cancer. 2020 Apr 14. doi: 10.1002/ijc.33008.
    >> Share

    December 2019
  13. POTTEGARD A, Kristensen KB, Friis S, Hallas J, et al
    Urinary tract infections and risk of squamous cell carcinoma bladder cancer: A Danish nationwide case-control study.
    Int J Cancer. 2019 Dec 21. doi: 10.1002/ijc.32842.
    >> Share

    November 2019
  14. VRIELING A, Bueno-De-Mesquita HB, Ros MM, Kampman E, et al
    One-carbon metabolism biomarkers and risk of urothelial cell carcinoma in the European prospective investigation into cancer and nutrition.
    Int J Cancer. 2019;145:2349-2359.
    >> Share

    October 2019
  15. ZENG H, Liu Z, Wang Z, Zhou Q, et al
    Intratumoral IL22-producing cells define immunoevasive subtype muscle-invasive bladder cancer with poor prognosis and superior nivolumab responses.
    Int J Cancer. 2019 Oct 4. doi: 10.1002/ijc.32715.
    >> Share

  16. JACK S, Madhivanan K, Ramadesikan S, Subramanian S, et al
    A Novel, Safe, Fast, Efficient Treatment for Her2-positive and Negative Bladder Cancer Utilizing an EGF-Anthrax Toxin Chimera.
    Int J Cancer. 2019 Oct 4. doi: 10.1002/ijc.32719.
    >> Share

    August 2019
  17. TURNER MC, Gracia-Lavedan E, Cirac M, Castano-Vinyals G, et al
    Reply to: Air pollution and incident bladder cancer: a risk assessment.
    Int J Cancer. 2019 Aug 19. doi: 10.1002/ijc.32632.
    >> Share

  18. KAWADA T
    Air pollution and incident bladder cancer: a risk assessment.
    Int J Cancer. 2019 Aug 19. doi: 10.1002/ijc.32633.
    >> Share

    July 2019
  19. STROGGILOS R, Mokou M, Latosinska A, Makridakis M, et al
    Proteome-based classification of Non-Muscle Invasive Bladder Cancer.
    Int J Cancer. 2019 Jul 8. doi: 10.1002/ijc.32556.
    >> Share

    June 2019
  20. NAMEKAWA T, Ikeda K, Horie-Inoue K, Suzuki T, et al
    ALDH1A1 in patient-derived bladder cancer spheroids activates retinoic acid signaling leading to TUBB3 overexpression and tumor progression.
    Int J Cancer. 2019 Jun 12. doi: 10.1002/ijc.32505.
    >> Share

    May 2019
  21. LAAKSONEN MA, MacInnis RJ, Canfell K, Giles GG, et al
    The future burden of kidney and bladder cancers preventable by behaviour modification in Australia: a pooled cohort study.
    Int J Cancer. 2019 May 20. doi: 10.1002/ijc.32420.
    >> Share

  22. ZHANG K, Dai H, Liang W, Zhang L, et al
    Fermented dairy foods intake and risk of cancer.
    Int J Cancer. 2019;144:2099-2108.
    >> Share

    April 2019
  23. BASSETT JK, Brinkman MT, Dugue PA, Ueland PM, et al
    Circulating concentrations of B group vitamins and urothelial cell carcinoma.
    Int J Cancer. 2019;144:1909-1917.
    >> Share

  24. SUN M, Zhao W, Chen Z, Li M, et al
    Circular RNA CEP128 Promotes Bladder Cancer Progression by Regulating Mir-145-5p/Myd88 Via Mapk Signaling Pathway.
    Int J Cancer. 2019 Apr 2. doi: 10.1002/ijc.32311.
    >> Share

    February 2019
  25. WU Q, Fu C, Li M, Li J, et al
    CINP is a novel cofactor of KLF5 required for its role in the promotion of cell proliferation, survival and tumor growth.
    Int J Cancer. 2019;144:582-594.
    >> Share

    January 2019
  26. TURNER MC, Gracia-Lavedan E, Cirac M, Castano-Vinyals G, et al
    Ambient air pollution and incident bladder cancer risk: updated analysis of the Spanish Bladder Cancer Study.
    Int J Cancer. 2019 Jan 17. doi: 10.1002/ijc.32136.
    >> Share

    December 2018
  27. GE Q, Lu M, Ju L, Qian K, et al
    miR-4324-RACGAP1-STAT3-ESR1 feedback loop inhibits proliferation and metastasis of bladder cancer.
    Int J Cancer. 2018 Dec 3. doi: 10.1002/ijc.32036.
    >> Share

    October 2018
  28. LEAO R, Lee D, Figueiredo A, Hermanns T, et al
    Combined genetic and epigenetic alterations of the TERT promoter affect clinical and biological behaviour of bladder cancer.
    Int J Cancer. 2018 Oct 23. doi: 10.1002/ijc.31935.
    >> Share

    September 2018
  29. PIAO XM, Jeong P, Kim YH, Byun YJ, et al
    Urinary cell-free microRNA biomarker could discriminate bladder cancer from benign hematuria.
    Int J Cancer. 2018 Sep 5. doi: 10.1002/ijc.31849.
    >> Share

    August 2018
  30. HERMANS TJN, Voskuilen CS, Deelen M, Mertens LS, et al
    Superior Efficacy of Neoadjuvant Chemotherapy and Radical Cystectomy in cT3-4aN0M0 compared to cT2N0M0 Bladder Cancer.
    Int J Cancer. 2018 Aug 28. doi: 10.1002/ijc.31833.
    >> Share

    July 2018
  31. DUGUE PA, Brinkman MT, Hodge AM, Bassett JK, et al
    Dietary intake of nutrients involved in one-carbon metabolism and risk of urothelial cell carcinoma: A prospective cohort study.
    Int J Cancer. 2018;143:298-306.
    >> Share

  32. WANG W, Yang C, Nie H, Qiu X, et al
    LIMK2 acts as an oncogene in bladder cancer and its functional SNP in the microRNA-135a binding site affects bladder cancer risk.
    Int J Cancer. 2018 Jul 14. doi: 10.1002/ijc.31757.
    >> Share

  33. KOUTROS S, Baris D, Waddell R, Freeman LEB, et al
    Potential effect modifiers of the arsenic-bladder cancer risk relationship.
    Int J Cancer. 2018 Jul 7. doi: 10.1002/ijc.31720.
    >> Share

  34. LIN C, Travis RC, Appleby PN, Tipper S, et al
    Pre-diagnostic circulating insulin-like growth factor-I and bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition.
    Int J Cancer. 2018 Jul 4. doi: 10.1002/ijc.31650.
    >> Share

    May 2018
  35. TELEKA S, Haggstrom C, Nagel G, Bjorge T, et al
    Risk of bladder cancer by disease severity in relation to metabolic factors and smoking; a prospective pooled cohort study of 800,000 men and women.
    Int J Cancer. 2018 May 14. doi: 10.1002/ijc.31597.
    >> Share

    February 2018
  36. LIU X, Cheng X, Liu X, He L, et al
    Investigation of the urinary metabolic variations and the application in bladder cancer biomarker discovery.
    Int J Cancer. 2018 Feb 16. doi: 10.1002/ijc.31323.
    >> Share

    January 2018
  37. INOUE-CHOI M, Hartge P, Liao LM, Caporaso N, et al
    Association between long-term low-intensity cigarette smoking and incidence of smoking-related cancer in the national institutes of health-AARP cohort.
    Int J Cancer. 2018;142:271-280.
    >> Share

    December 2017
  38. YU Y, Jin H, Xu J, Gu J, et al
    XIAP overexpression promotes bladder cancer invasion in vitro and lung metastasis in vivo via enhancing nucleolin-mediated Rho-GDIbeta mRNA stability.
    Int J Cancer. 2017 Dec 18. doi: 10.1002/ijc.31223.
    >> Share

  39. SHI X, Zhang X, Li J, Mo L, et al
    PD-1 blockade enhances the anti-tumor efficacy of GM-CSF surface-modified bladder cancer stem cells vaccine.
    Int J Cancer. 2017 Dec 15. doi: 10.1002/ijc.31219.
    >> Share

  40. WESTHOFF E, Wu X, Kiemeney LA, Lerner SP, et al
    Dietary patterns and risk of recurrence and progression in non-muscle-invasive bladder cancer.
    Int J Cancer. 2017 Dec 13. doi: 10.1002/ijc.31214.
    >> Share

    September 2017
  41. RAVA M, Czachorowski MJ, Silverman D, Marquez M, et al
    Asthma status is associated with decreased risk of aggressive urothelial bladder cancer.
    Int J Cancer. 2017 Sep 22. doi: 10.1002/ijc.31066.
    >> Share

  42. MASAOKA H, Matsuo K, Sawada N, Yamaji T, et al
    Alcohol consumption and bladder cancer risk with or without the flushing response: The Japan Public Health Center-based Prospective Study.
    Int J Cancer. 2017 Sep 5. doi: 10.1002/ijc.31028.
    >> Share

    July 2017
  43. BOTTERI E, Ferrari P, Roswall N, Tjonneland A, et al
    Alcohol consumption and risk of urothelial cell bladder cancer in the European Prospective Investigation into Cancer and Nutrition cohort.
    Int J Cancer. 2017 Jul 19. doi: 10.1002/ijc.30894.
    >> Share

    January 2017
  44. SOAVE A, Riethdorf S, Dahlem R, von Amsberg G, et al
    A nonrandomized, prospective, clinical study on the impact of circulating tumor cells on outcomes of urothelial carcinoma of the bladder patients treated with radical cystectomy with or without adjuvant chemotherapy.
    Int J Cancer. 2017;140:381-389.
    >> Share

    December 2016
  45. HADKHALE K, Martinsen JI, Weiderpass E, Kjaerheim K, et al
    Occupational exposure to solvents and bladder cancer: A population-based case control study in Nordic countries.
    Int J Cancer. 2016 Dec 29. doi: 10.1002/ijc.30593.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016